Dermatology Times, August 2020 (Vol. 41, No. 8)

Survey findings inform messaging on UV exposure

July 31, 2020

Findings from a survey of college students examining beliefs about UV exposure and sunscreen use and their associations with skin cancer risk and UV protective behaviors provide some insights for patient counseling.

A new business model for dermatology

July 21, 2020

Dermatologists are some of the brightest and most entrepreneurial of all physicians. We can set up our own private equity firm and maintain control of our specialty. I believe it is possible. What do you think?

Is Covid-19 a defense to a battery charge?

July 20, 2020

Dr. Joe acquired a new laser prior to the pandemic. Three patients are scheduled for treatment during which he had told them a laser expert would be present. The laser expert deferred due to COVID-19. After carrying out the procedures alone, one patient sues for battery, though there were no adverse events. Is this battery? Can Dr. Joe use COVID-19 challenges as a defense?

A ‘biomarker’ of psychiatric adverse effects with isotretinoin?

July 17, 2020

While recognizing that a patient’s mental health generally improves with isotretinoin use due to improvement in acne symptoms, clinicians may consider screening for insomnia during the course of treatment, as it may be an indicator for vulnerability to side effects, researchers say.

Researchers encourage reporting on hormone therapy in acne trial demographics

July 16, 2020

Many current acne clinical trials do not consider those patients already on hormone therapy, which researchers say may affect therapeutic outcomes. Authors of a recent study encourage this reporting in future studies to help clinicians better assess how the data might represent a practice population.

First injectable for cellulite approved by FDA

July 08, 2020

The U.S. FDA has approved collagenase clostridium histolyticum-aaes (Qwo, Endo International), making it the first FDA-approved injectable treatment for moderate-to-severe cellulite in the buttocks in adult women.

Nanotechnology: An opportunity to advance skin cancer treatment

July 01, 2020

In cancer immunotherapy, nanoparticles can be directed to different cells and tissues related to the immune response. This technology is currently being investigated to enhance drug delivery in skin cancer therapy with the hope of promoting more robust antitumor effects and improved clinical outcomes.

Biologics enter post-PASI era

June 26, 2020

With newer biologics consistently posting PASI improvements greater than 90%, dermatologists need to consider other factors when selecting a treatment. However, nuanced differences between the same drug class could be teased out, one expert says.

No evidence of increased cancer incidence in children using topical

June 24, 2020

A recent study shows no increased risk of incidence of malignancies in patients using topical tacrolimus. A black box warning on the therapy has made it challenging for physicians to prescribe, and researchers hope this evidence will lead to the FDA reconsidering that warning.

No added benefit combining CaHA, HIFU

June 22, 2020

Study demonstrates CaHA and HIFU monotherapies are safe and effective treatments for acne scarring; however, further investigations need to address the study’s limitations and explore combination approaches.

Consider lesion biopsy in patients with history of certain cancers

May 04, 2020

While little is known about BPDCN  and how to treat it, authors of a recent study suggest a low threshold for performing a skin biopsy to evaluate skin lesions in patients with hematological cancers, especially when those lesions that are quickly progressing, large or involve atypical sites.

Red light treatment proves safe, effective for androgenetic alopecia

April 06, 2020

REVIAN Inc. releases data from their investigational study examining their REVIAN RED dual wavelength LED light treatment for androgenetic alopecia, showing the FDA-cleared device to be both safe and effective at week 16 in a 26-week trial.

Challenges with treating eyelid eczema

November 19, 2019

Not treating, incorrectly treating or undertreating eyelid eczema can result in significant patient suffering. Finding the root of the problem is key to safe and effective therapy, Dr. Peter Lio says.